Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
HK Stock MarketDetailed Quotes
SINOPHARM (01099)
- 20.620
- +0.180+0.88%
Market Closed Jan 16 16:07 CST
64.35BMarket Cap8.30P/E (TTM)
20.660High20.440Low3.61MVolume20.440Open20.440Prev Close74.18MTurnover0.27%Turnover Ratio8.45P/E (Static)3.12BShares21.66052wk High0.71P/B27.67BFloat Cap16.00152wk Low0.74Dividend TTM1.34BShs Float39.285Historical High0.739Dividend LFY1.08%Range %8.017Historical Low20.552Avg Price400Lot Size3.58%Div Yield TTM3.58%Div Yield LFY
SINOPHARM (01099) Cash Flow
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -5.09%7.21B | ---- | -28.25%14B | ---- | -14.32%7.6B | ---- | 5.11%19.51B | ---- | 10.77%8.87B |
| Profit adjustment | ||||||||||
| Dividend (income)- adjustment | ---- | 29.66%-396K | ---- | 89.00%-4.41M | ---- | 7.10%-563K | ---- | -206.83%-40.05M | ---- | -13.27%-606K |
| Attributable subsidiary (profit) loss | ---- | -10.11%-687.85M | ---- | -8.31%-1.2B | ---- | -8.78%-624.72M | ---- | -3.78%-1.11B | ---- | -16.51%-574.28M |
| Impairment and provisions: | ---- | 6.24%1.41B | ---- | 231.98%2.56B | ---- | 0.72%1.33B | ---- | 5.86%772.55M | ---- | 33.26%1.32B |
| -Other impairments and provisions | ---- | 6.24%1.41B | ---- | 231.98%2.56B | ---- | 0.72%1.33B | ---- | 5.86%772.55M | ---- | 33.26%1.32B |
| Revaluation surplus: | ---- | 21.46%-2.48M | ---- | 224.46%78.33M | ---- | -4,251.32%-3.16M | ---- | -377.34%-62.93M | ---- | 100.98%76K |
| -Other fair value changes | ---- | 21.46%-2.48M | ---- | 224.46%78.33M | ---- | -4,251.32%-3.16M | ---- | -377.34%-62.93M | ---- | 100.98%76K |
| Asset sale loss (gain): | ---- | -15.15%1.1B | ---- | 11.33%2.46B | ---- | -25.42%1.3B | ---- | -57.30%2.21B | ---- | 8,808.00%1.75B |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 80.14%-5.51M | ---- | -88.32%-9.43M | ---- | -176.25%-27.74M | ---- | 32.50%-5.01M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 135.09%1.19M | ---- | 100.08%187K | ---- | 96.23%-3.39M | ---- | -1,270.30%-235.93M | ---- | -1,804.81%-89.89M |
| -Loss (gain) from selling other assets | ---- | -16.06%1.1B | ---- | -0.33%2.46B | ---- | -28.57%1.31B | ---- | -52.02%2.47B | ---- | 23,389.04%1.84B |
| Depreciation and amortization: | ---- | -3.95%2.23B | ---- | 6.85%4.73B | ---- | 10.73%2.33B | ---- | 6.37%4.43B | ---- | 4.95%2.1B |
| -Depreciation | ---- | -3.96%903.84M | ---- | 3.16%1.91B | ---- | 14.50%941.11M | ---- | 3.94%1.86B | ---- | -4.61%821.95M |
| -Amortization of intangible assets | ---- | 3.09%214.85M | ---- | 6.22%441.81M | ---- | -17.39%208.41M | ---- | 6.47%415.93M | ---- | 41.25%252.29M |
| Special items | ---- | -350.21%-50.09M | ---- | -9.26%-108.08M | ---- | 25.45%-11.13M | ---- | -1.14%-98.92M | ---- | -104.28%-14.93M |
| Adjustment items | ---- | ---- | ---- | ---50M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -5.83%11.22B | ---- | -12.26%22.47B | ---- | -11.37%11.91B | ---- | -6.65%25.61B | ---- | 6.84%13.44B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 49.70%-4.46B | ---- | -547.82%-2.04B | ---- | -45.87%-8.88B | ---- | 104.79%455.56M | ---- | -9.67%-6.09B |
| Accounts receivable (increase)decrease | ---- | 23.91%-44.04B | ---- | -16.98%-17.49B | ---- | 19.14%-57.88B | ---- | -1,578.31%-14.96B | ---- | -78.80%-71.58B |
| Accounts payable increase (decrease) | ---- | -62.67%6.02B | ---- | -111.11%-964.07M | ---- | -32.83%16.12B | ---- | -12.40%8.68B | ---- | 691.93%24B |
| prepayments (increase)decrease | ---- | -1,194.92%-372.91M | ---- | -87.79%596.23M | ---- | -103.09%-28.8M | ---- | 165.10%4.89B | ---- | 141.16%933.46M |
| Special items for working capital changes | ---- | -112.33%-57.78M | ---- | 558.41%13.43B | ---- | 132.08%468.49M | ---- | -173.02%-2.93B | ---- | -528.35%-1.46B |
| Cash from business operations | ---- | 17.20%-31.7B | ---- | -26.42%16B | ---- | 6.06%-38.29B | ---- | -14.25%21.75B | ---- | -27.76%-40.76B |
| Other taxs | ---- | 10.93%-2.41B | ---- | 2.60%-4.46B | ---- | -5.35%-2.71B | ---- | -4.01%-4.58B | ---- | -7.46%-2.57B |
| Adjustment items of business operations | 18.11%-39.08B | ---- | 27.81%-34.28B | ---- | -20.29%-47.72B | ---- | -16.68%-47.48B | ---- | -26.22%-39.67B | ---- |
| Net cash from operations | 18.11%-39.08B | 16.79%-34.11B | 27.81%-34.28B | -32.77%11.55B | -20.29%-47.72B | 5.38%-40.99B | -16.68%-47.48B | -18.08%17.17B | -26.22%-39.67B | -26.34%-43.33B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 0.07%39.75M | ---- | -59.16%74.7M | ---- | 2.72%39.72M | ---- | 145.31%182.9M | ---- | -2.94%38.67M |
| Dividend received - investment | -47.93%149.12M | -68.30%77.67M | -91.29%1.09M | 76.06%738.28M | 67.00%286.4M | 309.39%245.03M | 29.46%12.54M | -25.79%419.34M | -34.28%171.5M | -40.13%59.85M |
| Restricted cash (increase) decrease | ---- | ---- | ---- | -2,579.71%-2.55B | ---- | -100.27%-4.8M | ---- | 105.83%102.91M | ---- | 54.58%1.76B |
| Sale of fixed assets | -85.51%16.43M | -91.49%7.91M | -94.97%2.26M | -85.59%65.74M | -67.36%113.37M | 85.47%92.91M | 717.81%44.86M | 164.67%456.13M | 1,127.92%347.35M | 20.02%50.09M |
| Purchase of fixed assets | 17.88%-1.14B | 38.75%-626.66M | 32.10%-321.22M | 24.91%-1.47B | -2.26%-1.38B | -42.23%-1.02B | -16.41%-473.1M | 7.88%-1.96B | 8.18%-1.35B | 17.32%-719.37M |
| Selling intangible assets | ---- | -95.83%681K | ---- | -97.00%6.28M | ---- | -30.07%16.32M | ---- | 4,467.04%209.08M | ---- | 148.54%23.33M |
| Purchase of intangible assets | ---- | 86.98%-35.59M | ---- | -31.98%-496.6M | ---- | -98.84%-273.35M | ---- | -29.58%-376.28M | ---- | -161.26%-137.47M |
| Sale of subsidiaries | ---- | -69.97%13.17M | ---- | 2.17%101.35M | --11.42M | -0.74%43.87M | ---- | -15.40%99.2M | ---- | 324.06%44.19M |
| Acquisition of subsidiaries | 95.60%-7.42M | ---- | ---- | -70.26%-223.13M | -126.41%-168.44M | -183.82%-103.51M | -271.22%-97.04M | 71.13%-131.05M | 28.05%-74.4M | 78.27%-36.47M |
| Recovery of cash from investments | -76.00%20.08M | -17.72%274K | -77.30%13.65M | -92.81%5.88M | 161.02%83.66M | -99.65%333K | 380.39%60.16M | -61.41%81.87M | 122.57%32.05M | -32.50%93.81M |
| Cash on investment | 52.48%-9.26M | ---- | ---- | ---- | 78.50%-19.48M | ---41K | 89.33%-4.92M | 99.58%-422K | 49.25%-90.57M | ---- |
| Other items in the investment business | 19.99%1.22B | 88.25%-8.44M | 29.16%921.71M | ---- | 3.60%1.01B | -21,939.26%-71.85M | -17.69%713.63M | ---28.64M | 124.68%978.9M | ---326K |
| Net cash from investment operations | 507.47%250.47M | 48.85%-531.24M | 141.09%617.49M | -297.12%-3.75B | -578.30%-61.47M | -187.97%-1.04B | -38.43%256.12M | 73.69%-944.54M | 101.27%12.85M | 201.89%1.18B |
| Net cash before financing | 18.74%-38.83B | 17.58%-34.64B | 28.73%-33.66B | -51.97%7.8B | -20.48%-47.78B | 0.27%-42.03B | -17.25%-47.23B | -6.59%16.23B | -22.24%-39.66B | -24.32%-42.15B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -0.34%89.23B | 11.62%60.83B | -2.45%32.58B | 4.43%97.43B | -7.93%89.54B | -12.12%54.49B | -9.95%33.39B | 4.63%93.29B | 7.23%97.25B | 13.87%62.01B |
| Refund | -14.16%-70.66B | -19.75%-42.34B | -1.26%-18.05B | -23.76%-102.66B | 11.02%-61.9B | -1.18%-35.35B | 16.81%-17.83B | 2.07%-82.95B | 1.10%-69.57B | -6.61%-34.94B |
| Issuance of bonds | ---- | -91.10%800M | ---- | -27.75%9.5B | ---- | 32.23%8.99B | ---- | -23.95%13.15B | ---- | 7.94%6.8B |
| Interest paid - financing | ---- | -1.16%-1.46B | ---- | -3.86%-3.32B | ---- | -1.64%-1.44B | ---- | 33.05%-3.2B | ---- | 23.17%-1.42B |
| Dividends paid - financing | 30.12%-4.54B | 32.37%-683.63M | 47.33%-584.07M | 14.09%-4.15B | 13.65%-6.49B | 10.49%-1.01B | 5.31%-1.11B | -20.59%-4.83B | -12.67%-7.52B | -39.57%-1.13B |
| Absorb investment income | -68.24%46.73M | -88.05%16.35M | -78.71%12.75M | 7.94%130.45M | 55.82%147.13M | 295.28%136.78M | 330.71%59.88M | -44.51%120.85M | -48.51%94.42M | -76.43%34.6M |
| Issuance expenses and redemption of securities expenses | ---- | 80.85%-574.4M | ---- | 42.82%-12B | ---- | 66.67%-3B | ---- | -23.43%-20.99B | ---- | -350.00%-9B |
| Other items of the financing business | -97.90%-2.54B | ---- | -114.09%-1.08B | 95.16%-5.71M | 50.08%-1.28B | ---- | 15.50%7.64B | -157.47%-118.13M | -166.71%-2.57B | -141.32%-33.16M |
| Net cash from financing operations | -42.33%11.54B | -27.71%15.58B | -41.88%12.88B | -126.13%-17.29B | 13.14%20.01B | 1.20%21.55B | 4.94%22.15B | -34.26%-7.64B | -0.16%17.69B | -5.41%21.3B |
| Effect of rate | 5.92%-4.48M | -425.58%-11.89M | -266.16%-1.08M | -319.13%-5.24M | -151.47%-4.76M | -33.11%3.65M | 112.76%651.16K | -79.25%2.39M | -67.16%9.25M | 0.76%5.46M |
| Net Cash | 1.74%-27.29B | 6.92%-19.06B | 17.11%-20.78B | -210.55%-9.49B | -26.39%-27.77B | 1.77%-20.48B | -30.80%-25.07B | -26.51%8.58B | -49.17%-21.97B | -83.07%-20.85B |
| Begining period cash | -14.88%54.31B | -14.88%54.31B | -14.88%54.31B | 15.55%63.81B | 15.55%63.81B | 15.55%63.81B | 14.56%63.81B | 26.86%55.22B | 26.86%55.22B | 26.86%55.22B |
| Cash at the end | -25.01%27.02B | -18.68%35.24B | -13.44%33.53B | -14.88%54.31B | 8.34%36.03B | 26.05%43.33B | 6.05%38.74B | 15.55%63.81B | 15.37%33.26B | 6.94%34.38B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian International Certified Public Accountants Limited, Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
New Consumption Stocks New Consumption Stocks
New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations. New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations.
View More
Hot Topics Hot Topics
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde
年頭旺到年尾
Aug 21, 2025 06:11
Are you foolish? What's the point of knowing your mistakes?
牛牛課堂
Sep 12, 2025 17:29
[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?